From CBC News:
An experimental obesity drug also appears to help reduce the health risks from Type 2 diabetes, researchers say.
The Sanofi-Aventis drug rimonabant, also called Acomplia, reduced risk factors for heart disease in people with Type 2 diabetes compared with those taking a placebo, European researchers report in Friday's online issue of the medical journal The Lancet. ...more
Sunday, November 05, 2006
Obesity drug may help Type 2 diabetes
I'm not sure if I've mentioned it here before, but I am predicting that Acomplia/rimonabant will be the biggest pharmaceutical phenomenon since Viagra.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment